Not independent
Tenure on this board
29.4 yrs
5 nominees · 6 ballot items.
Biomerica, Inc.'s 2025 annual meeting includes six management proposals: (1) election of five directors; (2) advisory say-on-pay for named executive officer compensation; (3) ratification of the independent registered public accounting firm; (4) amendment to the 2024 Stock Incentive Plan to increase authorized shares by 200,000; (5) amendment to the Amended and Restated Certificate of Incorporation to authorize the Board to increase authorized common stock from 25,000,000 to 300,000,000; and (6) adjournment of the annual meeting.
Election of five directors to serve until the next annual meeting of stockholders and until their successors are elected and qualified.
Advisory, non-binding vote on the compensation paid to Biomerica's Named Executive Officers as disclosed in this Proxy Statement.
Ratify Haskell & White LLP as Biomerica's independent registered public accounting firm for the fiscal year ending May 31, 2026.
Amend the 2024 Stock Incentive Plan to increase the total number of shares of common stock authorized for issuance by 200,000, bringing the total to 400,000.
Approve the Authorized Share Increase: amend the Articles to increase the number of authorized common stock from 25,000,000 to 300,000,000.
To approve an adjournment of the Annual Meeting.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 49,763 | $105K |
| 2 | BlackRock, Inc. | 0.6% | 18,636 | $40K |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 0.5% | 14,514 | $31K |
| 4 | LPL Financial LLC | 0.4% | 10,849 | $23K |
| 5 | VANGUARD FIDUCIARY TRUST CO | 0.2% | 6,613 | $14K |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.2% | 6,279 | $13K |
| 7 | HOLLENCREST CAPITAL MANAGEMENT | 0.0% | 825 | $2K |
| 8 | UBS Group AG | 0.0% | 458 | $971 |
| 9 | HARBOUR INVESTMENTS, INC. | 0.0% | 125 | $265 |
| 10 | UBS Group AG | 0.0% | 61 | $129 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.